Search Results 171-180 of 17106 for monoclonal antibody

1. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody that does inhibit CD38 activity (Deckert et al., 2014).For this first-in-human study, relapsed/refractory multiple myeloma has been ...

2. Mayo Clinic Study Suggests Two is Better Than One When Battling Agressive Lymphoma

   When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse ...

3. Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia - Mayo Clinic

   Monoclonal antibody, such as rituximab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...

4. Clinical trials - Oncology (Medical)

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

5. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

   Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...

6. LS138D, Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may find cancer cells and help kill them. Radioactive substances linked to monoclonal antibodies can bind to ...

7. Eculizumab-aagh (intravenous route) - Side effects & uses - Mayo Clinic

   ... antibody positive. Eculizumab-aagh injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted ...

8. Biological therapy for cancer - Mayo Clinic

   Cytokine therapy. Immune checkpoint inhibitors and modulators. Immunoconjugates. Immunotherapy. Monoclonal antibodies. Targeted therapy. Tumor-infiltrating ...

9. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

10. Ovarian Cancer Clinical Trials - Mayo Clinic Research

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. ... Monoclonal antibodies, such as ...